Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia

American Journal of Nephrology

Volumn 28, Issue 1, 2007, Pages 59-66

  Shiizaki, Kazuhiro ^a   Fukagawa, Masafumi ^b   Yuan, Qunsheng ^e   Hatamura, Ikuji ^c   Nii Kono, Tomoko ^b   Saji, Fumie ^c   Shigematsu, Takashi ^c   Akizawa, Tadao ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Gene; Hyperparathyroidism; Nephrectomy, 5 6; Polymerase chain reaction, real time; Vitamin D; Vitamin D metabolite

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NEPHRECTOMY; NONHUMAN; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SECONDARY HYPERPARATHYROIDISM; SPRAGUE DAWLEY RAT; STAINING; UREMIA;

ANIMALS; CALCITRIOL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; MALE; NEPHRECTOMY; PARATHYROID GLANDS; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; UREMIA; VITAMINS;

EID: 36249010945     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109240     Document Type: Article

References (16)

1. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, Numano M, Tanaka Y, Takagi H: Clonal analysis of parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996;20:744-750.
2. Chudek J, Ritz E, Kovacs G: Genetic abnormalities in parathyroid nodules of uremic patients. Clin Cancer Res 1998;4:211-214.
3. Shiizaki K, Hatamura I, Negi S, Narukawa N, Mizobuchi M, Sakaguchi T, Ooshima A, Akizawa T: Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia. Kidney Int 2003;64:992-1003.
4. Shiizaki K, Negi S, Mizobuchi M, Hatamura I, Narukawa N, Sakaguchi T, Kitabata Y, Sumikado S, Akizawa T: Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uremic patients. Nephrol Dial Transplant 2003;18(suppl 3):iii42-iii46.
5. Shiizaki K, Negi S, Hatamura I, Tatsuta K, Shibata M, Shimada S, Sakaguchi T, Akizawa T: Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cell. Kidney Int 2006;70(suppl 102):S12-S15.
6. Shiizaki K, Negi S, Hatamura I, Sakaguchi T, Saji F, Kunimoto K, Mizobuchi M, Imazeki I, Ooshima A, Akizawa T: Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats. J Am Soc Nephrol 2005;16:97-108.
7. Shiizaki K, Hayakawa N, Imazeki I, Hatamura I, Okada T, Negi S, Sakaguchi T, Shigematsu T, Akizawa T: Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells. Nephrol Dial Transplant 2007;22:1078-1086.
8. Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Kunimoto K, Okamoto M, Imazeki I, Muragaki Y, Akizawa T: Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism. Kidney Int 2006;70:486-495.
9. Dusso AS, Pavlopoulos T, Naumovich L, Lu Y, Finch J, Brown AJ, Morrissey J, Slatopolsky E: p21 WAF1 and transforming growth factor-α mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 2001;59:855-865.
10. Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H: Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism. Kidney Int 2002;62:1196-1207.
11. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H: Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998;17:2596-2606.
12. Yoshida T, Nakamura H, Masutani H, Yodoi J: The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process . Ann NY Acad Sci 2005;1055:1-12.
13. Blydt-Hansen TD, Tenenhouse HS, Goodyer P: PHEX expression in parathyroid gland and PTH dysregulation in X-linked hypophosphatemia. Pediatr Nephrol 1999;13:607-611.
14. Meyer RA Jr, Meyer MH, Morgan PL: Effects of altered diet on serum levels of 1,25-dihydroxyvitamin D and parathyroid hormone in X-linked hypophosphatemic (Hyp and Gy) mice. Bone 1996;18:23-28.
15. Pálmer HG, Larriba MJ, Garcia JM, Ordóñez- Morán P, Peña C, Peiró S, Puig I, Rodríguez R, de la Fuente R, Bernad A, Pollán M, Bonilla F, Gamallo C, de Herreros AG, Muñoz A: The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 2004;10:917-919.
16. Takeyama K, Masuhiro Y, Fuse H, Endoh H, Murayama A, Kitanaka S, Suzawa M, Yanagisawa J, Kato S: Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol Cell Biol 1999;19:1049-1055.